His and Her Health

FROM:The National Vulvodynia Association
Tuesday, February 7, 2012 12:35 AM


Researchers at the University of Ottawa are looking for women with vaginismus and provoked vestibulodynia (aka vulvar vestibulitis syndrome) to complete a questionnaire study on sexual health. Women between the ages of 18 and 44 who have always had difficulty with vaginal penetration or have had pain during half of all intercourse occasions are invited to participate in this research project.



Your participation in this research would involve completing a set of questionnaires at home and sending them anonymously to the Human Sexuality Research Laboratory at the University of Ottawa. Participants will also have the opportunity to receive information on treatment options.



For more information about this study, please call 613-562-5800 ex.2220 or email
sexualhealth@uottawa.ca.

Help NVA Collect Vital Data on Treatment Effectiveness
FROM:National Vulvodynia Association

Tuesday, January 31, 2012 1:06 PM


We Need Your Help to Study the Effectiveness of Vulvodynia Treatments

Vulvodynia Treatment Registry to Enroll 400 Women in 2012



Due to a prior lack of research, women with vulvodynia have almost no scientific information to help guide them in making important decisions about their medical treatment. Although medical professionals report utilizing as many as 30 different therapies to manage vulvodynia symptoms, currently, women can only determine treatment effectiveness through a trial-and-error process that can take many months.



Simply put, this is unacceptable and is the reason why NVA funded the National Vulvodynia Treatment Outcomes Registry. Women who participate in this important project are followed at one of eight Registry sites (see below) for one year after initiating vulvodynia treatment. Participation is voluntary, does not include any experimentation and does not change women's treatment recommendations. In addition to generating vital data on the effectiveness of treatments for different vulvodynia subtypes, collected information will help to identify factors that can predict treatment success and guide the development of large controlled trials of promising therapies. Additionally, we recently expanded the Registry project to include postmenopausal women, since this group is routinely excluded from research studies, as well as the collection of DNA samples, which will be used for genetic analyses.



Over the next 12 months, Investigators from nine states will enroll an additional 400 women in the Registry project. To speak to the Registry's Research Coordinator Katy Capote about participating at any of the sites, please call 407-303-2721 or send an email to katerina.capote@flhosp.org. To read more about the project, including information on the Registry Investigators, please visit NVA's web site. Medical professionals interested in obtaining Registry flyers to distribute to their patients should also contact Ms. Capote.



Registry sites are located in:

Arkansas (Little Rock)

California (Los Angeles)

Colorado (Denver)

Florida (Fort Lauderdale - coming soon)

Florida (Orlando)

Maryland (Annapolis)

New York (New York City - coming soon)

Ohio (Akron)

Pennsylvania (Pittsburgh - coming soon)

Washington DC

Here is a link to the new forum started by those who have ejaculatory anhedonia .
www.ejaculatoryanhedonia.com/index.php?

cjsteel ,whatever emails you are getting re: cialis are Not coming from this Bulletin Board.There is no way information on our members can be obtained. Posters are anonymous.

never heard of it.

Over the course of a woman’s lifetime, approximately 1 in 8 will be diagnosed with breast cancer. Most women are concerned about their risk for developing cancer and what they can do themselves to reduce their chances of getting the disease. Read the article by Dr. Michael Krychman at www.ourgyn.com/womens-sexual-health-main...isk-of-breast-cancer